• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHOU Yeshu, WANG Yanmei, ZHANG Beiyuan, WU Shuaicong, YANG Lei, YIN Lifang. Research progress of inorganic nanomaterials in drug delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(4): 394-405. DOI: 10.11665/j.issn.1000-5048.20200403
Citation: ZHOU Yeshu, WANG Yanmei, ZHANG Beiyuan, WU Shuaicong, YANG Lei, YIN Lifang. Research progress of inorganic nanomaterials in drug delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(4): 394-405. DOI: 10.11665/j.issn.1000-5048.20200403
shu

Research progress of inorganic nanomaterials in drug delivery system

  • Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China

Funds: This study was supported by the National Natural Science Foundation of China (No.81603051, No.81673377 and No.81871477);the National Science and Technology Major Project for Drug Innovation (No.2017ZX09101001-004);the Natural Science Foundation of Jiangsu Province (No.BK20160760 and No.BK20170748); the Fundamental Research Funds for the Central Universities (No.2016ZPY015);and the “333” High Level Talents Cultivation Project of Jiangsu Province
More Information
  • Received Date: November 17, 2019
    Graphical Abstract
    • Abstract
  • Efficient and safe delivery of drugs, proteins or genes to the targeted sites has been the focus of pharmaceutical research. Inorganic nanomaterials are ideal materials for drug delivery systems due to their good stability, excellent biocompatibility and high drug loading capacity.Inorganic nanomaterials are ideal materials for drug delivery systems due to their good stability, high biocompatibility and excellent drug loading capacity. In this review, we started with reported researches and clinical trials to discuss the researches and clinical transformation of these inorganic nanoparticles in application of drug delivery, including carbon nanomaterials, silica nanoparticles, calcium nanomaterials, gold nanoparticles, magnetic nanoparticles, upconversion nanoparticles and quantum dots, providing theoretical reference for application of inorganic drug delivery carriers in the development of new drugs, looking to the prospects of inorganic nanomaterials in clinical application.
    • FullText(HTML)
    • References (62)
  • [1]
    Bogart LK, Pourroy G, Murphy CJ, et al. Nanoparticles for imaging, sensing, and therapeutic intervention[J].ACS Nano, 2014, 8（4）: 3107-3122.
    [2]
    Cho EC, Glaus C, Chen J, et al. Inorganic nanoparticle-based contrast agents for molecular imaging[J]. Trends Mol Med, 2010, 16（12）: 561-573.
    [3]
    Panwar N, Soehartono AM, Chan KK, et al. Nanocarbons for biology and medicine: sensing, imaging, and drug delivery[J]. Chem Rev, 2019, 119（16）: 9559-9656.
    [4]
    Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM, et al. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes[J].Biomaterials, 2011, 32（4）: 1121-1129.
    [5]
    Miao W, Shim G, Lee S, et al. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer[J].Biomaterials, 2013, 34（13）: 3402-3410.
    [6]
    Islami M, Zarrabi A, Tada S, et al. Controlled quercetin release from high-capacity-loading hyperbranched polyglycerol-functionalized graphene oxide[J]. Int J Nanomed, 2018, 13: 6059-6071.
    [7]
    Liu Z, Zhang J, Tian Y, et al. Targeted delivery of reduced graphene oxide nanosheets using multifunctional ultrasound nanobubbles for visualization and enhanced photothermal therapy[J].Int J Nanomed, 2018, 13: 7859-7872.
    [8]
    Bhatnagar I, Venkatesan J, Kiml SK. Polymer functionalized single walled carbon nanotubes mediated drug delivery of gliotoxin in cancer cells[J].J Biomed Nanotechnol, 2014, 10（1）: 120-130.
    [9]
    Wu H, Shi H, Zhang H, et al. Prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery[J].Biomaterials, 2014, 35（20）: 5369-5380.
    [10]
    Chen D, Wang C, Jiang F, et al. In vitro and in vivo photothermally enhanced chemotherapy by single-walled carbon nanohorns as a drug delivery system[J]. J Mater Chem B, 2014, 2（29）: 4726-4732.
    [11]
    Yang J, Su H, Sun W, et al. Dual chemodrug-loaded single-walled carbon nanohorns for multimodal imaging-guided chemo-photothermal therapy of tumors and lung metastases[J]. Theranostics, 2018, 8（7）: 1966-1984.
    [12]
    Chien YH, Chan KK, Anderson T, et al. Advanced near-infrared light-responsive nanomaterials as therapeutic platforms for cancer therapy[J]. Adv Ther, 2019, 2（3）: 1800090.
    [13]
    Wang H, Di J, Sun Y, et al. Biocompatible PEG-chitosan@carbon dots hybrid nanogels for two-photon fluorescence imaging, near-infrared light/pH dual-responsive drug carrier, and synergistic therapy[J]. Adv Funct Mater, 2015, 25（34）: 5537-5547.
    [14]
    Tang J, Kong B, Wu H, et al. Carbon nanodots featuring efficient FRET for real-time monitoring of drug delivery and two-photon imaging[J]. Adv Mater, 2013, 25（45）: 6569-6574.
    [15]
    Jung YK, Shin E, Kim BS. Cell nucleus-targeting zwitterionic carbon dots[J]. Sci Rep, 2015, 5: 18807-18807.
    [16]
    Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery[J]. Adv Mater, 2012, 24（12）: 1504-1534.
    [17]
    Mellaerts R, Mols R, Jammaer JA, et al. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica[J]. Eur J Pharm Biopharm, 2008, 69（1）: 223-230.
    [18]
    Slowing II, Trewyn BG, Lin VS. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins[J]. J Am Chem Soc, 2007, 129（28）: 8845-8849.
    [19]
    Xia T, Kovochich M, Liong M, et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs[J]. ACS Nano, 2009, 3（10）: 3273-3286.
    [20]
    Zhang Z, Wang L, Wang J, et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment[J]. Adv Mater, 2012, 24（11）: 1418-1423.
    [21]
    Qi C, Lin J, Fu H, et al. Calcium-based biomaterials for diagnosis, treatment, and theranostics[J]. Chem Soc Rev, 2018, 47（2）: 357-403.
    [22]
    Li WM, Chiang CS, Huang WC, et al. Amifostine-conjugated pH-sensitive calcium phosphate-covered magnetic-amphiphilic gelatin nanoparticles for controlled intracellular dual drug release for dual-targeting in HER-2-overexpressing breast cancer[J]. J Control Release, 2015, 220（Pt A）: 107-118.
    [23]
    Zhang J, Sun X, Shao R, et al. Polycation liposomes combined with calcium phosphate nanoparticles as a non-viral carrier for siRNA delivery[J]. J Drug Deliv Sci Tec, 2015, 30（Part A）: 1-6.
    [24]
    Chen J, Sun X, Shao R, et al. VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer[J]. Int J nanomed, 2017, 12: 6075-6088.
    [25]
    Liu Y, Wang T, He F, et al. An efficient calcium phosphate nanoparticle-based nonviral vector for gene delivery[J]. Int J nanomed, 2011, 6: 721-727.
    [26]
    Qiu C, Wei W, Sun J, et al. Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy[J]. Nanoscale, 2016, 8（26）: 13033-13044.
    [27]
    Zhao Y, Lu Y, Hu Y, et al. Synthesis of superparamagnetic CaCO3 mesocrystals for multistage delivery in cancer therapy[J]. Small, 2010, 6（21）: 2436-2442.
    [28]
    Shafiu KA, Ismail M, Tengku Ibrahim TA, et al. A pH-sensitive, biobased calcium carbonate aragonite nanocrystal as a novel anticancer delivery system[J]. Biol Med Res Int, 2013, 2013（3）: 587451-587451.
    [29]
    Wu JL, He XY, Jiang PY, et al. Biotinylated carboxymethyl chitosan/CaCO3 hybrid nanoparticles for targeted drug delivery to overcome tumor drug resistance[J]. RSC Adv, 2016, 6（73）: 69083-69093.
    [30]
    Wu J, Zhu YJ, Cao SW, et al. Hierachically nanostructured mesoporous spheres of calcium silicate hydrate: surfactant-free sonochemical synthesis and drug-delivery system with ultrahigh drug-loading capacity[J]. Adv Mater, 2010, 22（6）: 749-753.
    [31]
    Wu C, Chang J, Fan W. Bioactive mesoporous calcium-silicate nanoparticles with excellent mineralization ability, osteostimulation, drug-delivery and antibacterial properties for filling apex roots of teeth[J]. J Mater Chem, 2012, 22（33）: 16801-16809.
    [32]
    Yuan Z, Lu F, Peng M, et al. Selective colorimetric detection of hydrogen sulfide based on primary amine-active ester cross-linking of gold nanoparticles[J]. Anal Chem, 2015, 87（14）: 7267-7273.
    [33]
    Hostetler MJ, Green SJ, Stokes JJ, et al. Monolayers in three dimensions: synthesis and electrochemistry of ω-functionalized alkanethiolate-stabilized gold cluster compounds[J]. J Am Chem Soc, 1996, 118（17）: 4212-4213.
    [34]
    Daniel MC, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology[J]. Chem Rev, 2004, 104（1）: 293-346.
    [35]
    Mieszawska AJ, Mulder WJM, Fayad ZA, et al. Multifunctional gold nanoparticles for diagnosis and therapy of disease[J]. Mol Pharm, 2013, 10（3）: 831-847.
    [36]
    Tomuleasa C, Soritau O, Orza A, et al. Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells[J]. J Gastrointestin Liver Dis, 2012, 21（2）: 187-196.
    [37]
    Heo DN, Yang DH, Moon HJ, et al. Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy[J]. Biomaterials, 2012, 33（3）: 856-866.
    [38]
    Lee SE, Sasaki DY, Perroud TD, et al. Biologically functional cationic phospholipid-gold nanoplasmonic carriers of RNA[J]. J Am Chem Soc, 2009, 131（39）: 14066-14074.
    [39]
    Shim MS, Kim CS, Ahn YC, et al. Combined multimodal optical imaging and targeted gene silencing using stimuli-transforming nanotheragnostics[J]. J Am Chem Soc, 2010, 132（24）: 8316-8324.
    [40]
    Gilchrist RK, Medal R, Shorey WD, et al. Selective inductive heating of lymph nodes[J]. Ann Surg, 1957, 146（4）: 596-606.
    [41]
    Meyers PH, Cronic F, Nice CM, et al. Experimental approach in the use and magnetic control of metallic iron particles in the lymphatic and vascular system of dogs as a contrast and isotopic agent[J]. Am J Roentgenol Radium Ther Nucl Med, 1963, 90: 1068-1077.
    [42]
    Shah BP, Pasquale N, De G, et al. Core-shell nanoparticle-based peptide therapeutics and combined hyperthermia for enhanced cancer cell apoptosis[J]. ACS Nano, 2014, 8（9）: 9379-9387.
    [43]
    Chen ML, He YJ, Chen XW, et al. Quantum dots conjugated with Fe3O4-filled carbon nanotubes for cancer-targeted imaging and magnetically guided drug delivery[J]. Langmuir, 2012, 28（47）: 16469-16476.
    [44]
    Hafeli UO. Magnetically modulated therapeutic systems[J]. Int J Pharm, 2004, 277（1/2）: 19-24.
    [45]
    Chen H, Langer R. Magnetically-responsive polymerized liposomes as potential oral delivery vehicles[J]. Pharm Res, 1997, 14（4）: 537-540.
    [46]
    Edelman ER, Langer R. Optimization of release from magnetically controlled polymeric drug release devices[J]. Biomaterials, 1993, 14（8）: 621-626.
    [47]
    Bae KH, Lee K, Kim C, et al. Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging[J]. Biomaterials, 2011, 32（1）: 176-184.
    [48]
    Zheng Y, Zhang H, Hu Y, et al. MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction[J]. Int J nanomed, 2018, 13: 6177-6188.
    [49]
    Yang G, Xu L, Chao Y, et al. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses[J]. Nat commun, 2017, 8（1）: 902.
    [50]
    Wang F, Li C, Cheng J, et al. Recent advances on inorganic nanoparticle-based cancer therapeutic agents[J]. Inter J Env Res Pub Heal, 2016, 13（12）: 1182.
    [51]
    Zhang P, Steelant W, Kumar M, et al. Versatile photosensitizers for photodynamic therapy at infrared excitation[J]. J Am Chem Soc, 2007, 129（15）: 4526-4527.
    [52]
    Zeng L, Luo L, Pan Y, et al. In vivo targeted magnetic resonance imaging and visualized photodynamic therapy in deep-tissue cancers using folic acid-functionalized superparamagnetic-upconversion nanocomposites[J]. Nanoscale, 2015, 7（19）: 8946-8954.
    [53]
    Cui S, Yin D, Chen Y, et al. In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct[J]. ACS Nano, 2013, 7（1）: 676-688.
    [54]
    Wang C, Tao H, Cheng L, et al. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles[J]. Biomaterials, 2011, 32（26）: 6145-6154.
    [55]
    Matea CT, Mocan T, Tabaran F, et al. Quantum dots in imaging, drug delivery and sensor applications[J]. Int J nanomed, 2017, 12: 5421-5431.
    [56]
    Bagalkot V, Zhang L, Levy-Nissenbaum E, et al. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer[J]. Nano Lett, 2007, 7（10）: 3065-3070.
    [57]
    Byrne S, Corr S, Rakovich T, et al. Optimisation of the synthesis and modification of CdTe quantum dots for enhanced live cell imaging[J]. J Mater Chem, 2006, 16（28）: 2896.
    [58]
    Cai X, Luo Y, Zhang W, et al. pH-sensitive ZnO quantum dots-doxorubicin nanoparticles for lung cancer targeted drug delivery[J]. ACS Appl Mater Interfaces, 2016, 8（34）: 22442-22450.
    [59]
    Bwatanglang IB, Mohammad F, Yusof NA, et al. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system[J]. J Colloid Interface Sci, 2016, 480: 146-158.
    [60]
    Singh RD, Shandilya R, Bhargava A, et al. Quantum dot based nano-biosensors for detection of circulating cell free miRNAs in lung carcinogenesis: from biology to clinical translation[J]. Front Genet, 2018, 9: 616.
    [61]
    Hirsch LR, Stafford RJ, Bankson JA, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance[J]. Proc Natl Acad Sci U S A, 2003, 100（23）: 13549-13554.
    [62]
    Anselmo AC, Mitragotri S. A review of clinical translation of inorganic nanoparticles[J]. AAPS J, 2015, 17（5）: 1041-1054.
    • Related Articles

  • Related Articles

    [1]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [2]CHEN Ye, YIN Jun, YAO Wenbing, GAO Xiangdong. Advances of DNA-based nanomaterials in tumor therapy[J]. Journal of China Pharmaceutical University, 2020, 51(4): 406-417. DOI: 10.11665/j.issn.1000-5048.20200404
    [3]YANG Ruocong, DUAN Feipeng, CHAO Jiahong, TIAN Pengpeng, YAN Zhiyong, LI Shaojing. Advances of microRNA activity in innate immunity[J]. Journal of China Pharmaceutical University, 2017, 48(4): 396-406. DOI: 10.11665/j.issn.1000-5048.20170403
    [4]CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203
    [5]JIANG Lu, CHEN Dandan, SUN Minjie, PING Qineng, ZHANG Can. Advances of wax matrix tablets[J]. Journal of China Pharmaceutical University, 2016, 47(4): 497-502. DOI: 10.11665/j.issn.1000-5048.20160418
    [6]YAO Guilin, WANG Haiyong, LU Tao. Advances of the uricosuric drugs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 491-496. DOI: 10.11665/j.issn.1000-5048.20160417
    [7]ZHANG Fangrong, WANG Wei. Advances of synthetic lipoproteins as drug nanovectors[J]. Journal of China Pharmaceutical University, 2016, 47(2): 148-157. DOI: 10.11665/j.issn.1000-5048.20160204
    [8]CHEN Qingyu, ZHOU Jianping, HUO Meirong. Advances in the nanotechnology-based drug delivery systems of silymarin[J]. Journal of China Pharmaceutical University, 2015, 46(3): 376-384. DOI: 10.11665/j.issn.1000-5048.20150320
    [9]WANG Ruoning, LIU Congyan, ZHOU Jianping, CHEN Jian, WANG Wei. Advances in the research of lipoprotein-based nano scale drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(1): 10-16. DOI: 10.11665/j.issn.1000-5048.20140102
    [10]XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106.

  • Cited by

    Periodical cited type(9)

    1. 蔡鸿飞，张琴，关伟键，杨阳，袁诚，许文东. 不同干燥方式对灵芝孢子粉中灵芝孢子油过氧化值的影响. 广东化工. 2024(01): 28-30 .
    2. 林志彬. 灵芝孢子油的药效物质基础研究进展. 菌物研究. 2024(01): 79-87 .
    3. Jianying Liu，Binzhi Zhang，Leqi Wang，Shasha Li，Qinqiang Long，Xue Xiao. Bioactive components, pharmacological properties and underlying mechanism of Ganoderma lucidum spore oil: A review. Chinese Herbal Medicines. 2024(03): 375-391 .
    4. 武美华，张胜男，敬隆鑫，律凤霞. 灵芝的活性成分及其药理作用的研究进展. 中国林副特产. 2023(02): 76-79 .
    5. 夏凤娜，关小莺，陈少丹，陈秋颜，张一帆，杨小兵. 灵芝孢子粉脂质成分HPLC-ELSD指纹图谱构建及含量测定. 食用菌学报. 2023(06): 52-59 .
    6. 井子良，吴纯宇，张慧敏，孙建博. 灵芝孢子油番茄红素复合物的抗肿瘤作用. 现代食品科技. 2022(09): 46-51 .
    7. 李志强，何玉霞. 灵芝多糖对人肺癌A549细胞增殖凋亡的作用. 现代食品科技. 2021(05): 38-42 .
    8. 张琴，李康强，杨阳，张圳，蔡鸿飞，许文东. 不同提取方式的灵芝孢子油品质研究. 广东化工. 2021(11): 48-49 .
    9. 包县峰，徐勇，刘维明，王星丽，孙培龙，张安强. 灵芝孢子粉生物活性成分及药理作用. 食品工业科技. 2020(06): 325-331 .

    Other cited types(6)

Catalog

    Get Citation
    PDF
    XML
    Article views (570) PDF downloads (698) Cited by(15)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：286500

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return